Glenn A Jacobson
7PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 16, 2024
Beta2-adrenergic agonist salbutamol exhibits enantioselective disposition in skeletal muscle of lean young men following oral administration.Morten Hostrup, Glenn A Jacobson, Kasper Eibye
|Apr 03, 2021
An Abductive Inference Approach to Assess the Performance-Enhancing Effects of Drugs Included on the World Anti-Doping Agency Prohibited List.Andreas Breenfeldt Andersen, Glenn A Jacobson, Jacob Bejder
|Apr 22, 2020
The salmeterol anomaly and the need for a urine threshold.Glenn A Jacobson, Morten Hostrup
|Jan 22, 2020
Anabolic and lipolytic actions of beta2 -agonists in humans and antidoping challenges.Morten Hostrup, Glenn A Jacobson, Søren Jessen
|Dec 31, 2019
Beta2 -adrenergic agonist clenbuterol increases energy expenditure and fat oxidation, and induces mTOR phosphorylation in skeletal muscle of young healthy men.Søren Jessen, Sara A Solheim, Glenn A Jacobson
|Mar 14, 2019
Enantioselective disposition of (R,R)-formoterol, (S,S)-formoterol and their respective glucuronides in urine following single inhaled dosing and application to doping control.Glenn A Jacobson, Morten Hostrup, Christian K Narkowicz
Pageof 2
Frequent Collaborators
7 joint publications
Morten Hostrup
4 joint publications
Søren Jessen
1 joint publications
Sara A Solheim
1 joint publications
Kasper Eibye
1 joint publications
Jens Bangsbo
1 joint publications
Nikolai B Nordsborg
1 joint publications
Anders Krogh Lemminger
1 joint publications
Andreas Breenfeldt Andersen
1 joint publications
Jacob Bejder
1 joint publications
Dino Premilovac
